Search research articles
Contact Us
Filters
Showing results (151-160 of 187) with videos related to
Page
of 19
Sort By:
Blood Advances
|
May 13, 2024
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16
Peter Mollee, John Reynolds, Wojt Janowski, et al.
Leukemia & Lymphoma
|
July 15, 2021
Cereblon pathway biomarkers and immune profiles in patients with myeloma receiving post-ASCT lenalidomide maintenance (LEOPARD)
Anna Kalff, Tiffany Khong, Malarmathy Ramachandran, et al.
Haematologica
|
October 14, 2011
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia
Harry Iland, Ken Bradstock, John Seymour, et al.
Ebiomedicine
|
December 3, 2025
Development and validation of a bronchoalveolar lavage genomic classifier for acute cellular rejection
S Samuel Weigt, Jin Zhou, Tomoki Okuno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 21, 2020
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy
Chong Chyn Chua, Andrew W Roberts, John Reynolds, et al.
Blood
|
March 22, 2013
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML
Susan Branford, David T Yeung, David M Ross, et al.
Annals of Internal Medicine
|
June 16, 2010
Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial
Scott M Palmer, Ajit P Limaye, Missy Banks, et al.
Nature Communications
|
September 1, 2018
Restricted cell cycle is essential for clonal evolution and therapeutic resistance of pre-leukemic stem cells
Cedric S Tremblay, Jesslyn Saw, Sung Kai Chiu, et al.
American Journal of Hematology
|
March 2, 2017
Dynamic assessment of RBC-transfusion dependency improves the prognostic value of the revised-IPSS in MDS patients
Devendra K Hiwase, Deepak Singhal, Corinna Strupp, et al.
Haematologica
|
October 7, 2017
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome
Deepak Singhal, Monika M Kutyna, Rakchha Chhetri, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 187) with videos related to
Sort By:
Page
of 19
Blood Advances
|
May 13, 2024
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16
Peter Mollee, John Reynolds, Wojt Janowski, et al.
Leukemia & Lymphoma
|
July 15, 2021
Cereblon pathway biomarkers and immune profiles in patients with myeloma receiving post-ASCT lenalidomide maintenance (LEOPARD)
Anna Kalff, Tiffany Khong, Malarmathy Ramachandran, et al.
Haematologica
|
October 14, 2011
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia
Harry Iland, Ken Bradstock, John Seymour, et al.
Ebiomedicine
|
December 3, 2025
Development and validation of a bronchoalveolar lavage genomic classifier for acute cellular rejection
S Samuel Weigt, Jin Zhou, Tomoki Okuno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 21, 2020
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy
Chong Chyn Chua, Andrew W Roberts, John Reynolds, et al.
Blood
|
March 22, 2013
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML
Susan Branford, David T Yeung, David M Ross, et al.
Annals of Internal Medicine
|
June 16, 2010
Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial
Scott M Palmer, Ajit P Limaye, Missy Banks, et al.
Nature Communications
|
September 1, 2018
Restricted cell cycle is essential for clonal evolution and therapeutic resistance of pre-leukemic stem cells
Cedric S Tremblay, Jesslyn Saw, Sung Kai Chiu, et al.
American Journal of Hematology
|
March 2, 2017
Dynamic assessment of RBC-transfusion dependency improves the prognostic value of the revised-IPSS in MDS patients
Devendra K Hiwase, Deepak Singhal, Corinna Strupp, et al.
Haematologica
|
October 7, 2017
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome
Deepak Singhal, Monika M Kutyna, Rakchha Chhetri, et al.
Page
of 19